Expertise in
46
conditions

Dr. Alison E. Spellman

Oncology
Summit Cancer Care, PC
225 Candler Dr Ste 300, 
Savannah, GA 
Accepting New Patients
Offers Telehealth
15 Years of Experience
Expertise in
46
conditions
Summit Cancer Care, PC
225 Candler Dr Ste 300, 
Savannah, GA 

Overview

Alison Spellman is an Oncologist practicing medicine in Savannah, Georgia. She has been practicing medicine for over 15 years.

Dr. Spellman is highly rated in 46 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), Breast Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 5 clinical trials. Dr. Spellman is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in GA

Hospital Affiliations

Candler Hospital
Savannah Health Services LLC Dba Memorial Health University Medical Center
Effingham Health System
St Joseph's Hospital - Savannah

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Summit Cancer Care, PC
225 Candler Dr Ste 300, Savannah, GA 31405
Other Locations
Effingham Cancer Care Center
459 Georgia Highway 119 S Ste B, Springfield, GA 31329

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Procedure, Biological, Drug, Radiation
Study Drugs: Docetaxel, Nab-Paclitaxel, Paclitaxel, Pertuzumab, Trastuzumab, Trastuzumab Emtansine
Study Phase: Phase 2
The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared With T-DM1 and Tucatinib
The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared With T-DM1 and Tucatinib
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Trastuzumab Emtansine, Tucatinib
Study Phase: Phase 3
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: May 29, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients With HER2-Negative Breast Cancer and Brain Metastases
A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients With HER2-Negative Breast Cancer and Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Biological
Study Drug: Sacituzumab Govitecan
Study Phase: Phase 2
Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502
Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502
Enrollment Status: Terminated
Publish Date: January 16, 2025
Intervention Type: Procedure
View 4 Less Clinical Trials

1 Total Publications

Immunotherapy for breast cancer: past, present, and future.
Immunotherapy for breast cancer: past, present, and future.
Journal: Cancer metastasis reviews
Published: December 04, 2016
Similar Doctors
Expertise in
55
conditions
Expertise in
55
conditions
Referral may be required

Low Country Cancer Care Associates, PC

4700 Waters Ave Ste 201, 
Savannah, GA 
 (5.3 miles away)
Languages Spoken:
English, Castilian, French, Romanian, Spanish
See accepted insurances
Accepting New Patients

Ovidiu Negrea is an Oncologist practicing medicine in Savannah, Georgia. Dr. Negrea is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Thrombocytopenia, Familial Colorectal Cancer, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Negrea is currently accepting new patients.

Expertise in
34
conditions
Expertise in
34
conditions
Referral may be required

Low Country Cancer Care Associates, PC

4700 Waters Ave Ste 201, 
Savannah, GA 
 (5.3 miles away)
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients

Jennifer Yannucci is an Oncologist practicing medicine in Savannah, Georgia. Dr. Yannucci is highly rated in 34 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Bone Marrow Aspiration. Dr. Yannucci is currently accepting new patients.

Expertise in
91
conditions
Dr. Gary W. Thomas
Hematology | Oncology
Expertise in
91
conditions
Dr. Gary W. Thomas
Hematology | Oncology
Referral may be required

Sc Cancer Specialists-Hilton Head At St. Joseph's/Candler

45 Hospital Center Cmns, 
Hilton Head Island, SC 
 (30.1 miles away)
843-689-2895
Languages Spoken:
English, Castilian, Spanish
See accepted insurances
Accepting New Patients

Gary Thomas is a Hematologist and an Oncologist practicing medicine in Hilton Head Island, South Carolina. Dr. Thomas is highly rated in 91 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Paget Disease of the Breast, Richter Syndrome, and Chronic Lymphocytic Leukemia (CLL). Dr. Thomas is currently accepting new patients.

Frequently Asked Questions about Dr. Alison E. Spellman

Is Dr. Alison E. Spellman a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alison E. Spellman is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Alison E. Spellman specialize in?

While Dr. Alison E. Spellman is a Oncology, they have specific expertise in Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Alison E. Spellman participate in research or clinical trials?

Yes. Dr. Alison E. Spellman has published 1 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Alison E. Spellman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Alison E. Spellman accept my insurance?

Dr. Alison E. Spellman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Spellman's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 38 Advanced Conditions
    View All 112 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile